|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.68 MYR | -0.73% |
|
-7.48% | -4.90% |
| 24/05 | TMC Life Sciences’ Attributable Profit for Fiscal Q3 Shrinks | MT |
| 23/05 | TMC Life Sciences Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
TMC Life Sciences Berhad announced Cessation Of Office of DR LAM LEE G as Independent and Non Executive Chairman of Risk Committee. Age;63. Date of change; 31 May 2023.
The new composition of the Audit and Risk Management Committee is as follows: 1. Mr. Cheah Ho Chee (Chairman, Independent Non-Executive Director),2. Ms. June Leong Lai Ling (Member, Independent Non-Executive Director),3. Ms. Mazrina binti Arifin (Member, Independent Non-Executive Director).
| 1st Jan change | Capi. | |
|---|---|---|
| -4.90% | 254M | |
| -23.07% | 15.63B | |
| 0.00% | 12.28B | |
| +2.65% | 11.64B | |
| +3.49% | 10.2B | |
| +26.24% | 8.4B | |
| -11.21% | 7.31B | |
| +4.01% | 6.72B | |
| -3.76% | 5.82B | |
| -4.42% | 4.27B |
TMC LIFE SCIENCES 
